Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on February 19, 2009

Stroke. 2009
Published online before print February 19, 2009, doi: 10.1161/STROKEAHA.108.536714
A more recent version of this article appeared on April 1, 2009
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/4/1282    most recent
STROKEAHA.108.536714v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Altamura, C.
Right arrow Articles by Vernieri, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Altamura, C.
Right arrow Articles by Vernieri, F.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*COPPER, ELEMENTAL
*IRON
*Genetics Home Reference
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Pathophysiology
Right arrow Acute Cerebral Infarction

Submitted on September 8, 2008
Accepted on October 1, 2008

Ceruloplasmin/Transferrin System Is Related to Clinical Status in Acute Stroke

Claudia Altamura MD*; Rosanna Squitti PhD; Patrizio Pasqualetti PhD; Chiara Gaudino MD; Paola Palazzo MD; Francesco Tibuzzi MD; Domenico Lupoi MD; Maurizio Cortesi MD; Paolo Maria Rossini MD; and Fabrizio Vernieri MD

From the Neurologia Clinica (C.A., R.S., P. Palazzo, P.M.R., F.V.), Università Campus Bio-Medico di Roma; Associazione Fatebenefratelli per la Ricerca (AFaR), Dipartimento di Neuroscienze (C.A., R.S., P. Pasqualetti, F.T., D.L., M.C., P.M.R., F.V.), Fatebenefratelli, Isola Tiberina, Rome; Casa di Cura San Raffaele (P. Pasqualetti, P.M.R.), Cassino & IRCCS San Raffaele Pisana, Rome; and Dipartimento di Radiologia (C.G.), Università Campus Bio-Medico di Rome, Italy.

* To whom correspondence should be addressed. E-mail: c.altamura{at}unicampus.it.

Background and Purpose—In acute stroke, Iron (Fe) may amplify reperfusion injury by catalyzing the conversion of superoxide and hydrogen peroxide into highly reactive radicals. Transferrin (Tf) is the main protein regulating Fe homeostasis, whereas Ceruplasmin (CP) is a circulating ferroxidase enzyme able to oxidize ferrous ions to less toxic ferric forms. This study aims at investigating whether CP, Copper (Cu), Tf, and Fe play a role in the pathophysiology of acute stroke.

Methods—We enrolled 35 acute stroke patients and 44 controls. All patients underwent: neurological examination assessed by National Institutes of Health Stroke Scale (NIHSS), ultrasound evaluation of carotid atherosclerosis, brain MRI to quantify ischemic lesion volume and measurement of serum levels of CP, Cu, Tf, Fe, hydro-peroxides, and Total plasmatic antioxidant capacity.

Results—In patients, NIHSS scores were associated with Tf (r=-0.48, P=0.004), hydro-peroxides (r=0.34, P=0.046), CP (r=0.43, P=0.012), and lesion volume (r=0.50, P=0.004). Lesion volume was inversely associated with Tf (r=-0.44, P=0.012). CP and hydro-peroxides were also largely related (r=0.81, P<0.001). The model multiple R was 0.57, resulting in a 32.5% of explained NIHSS variance with Tf accounting for 23.4% and CP for 9.1%.

Conclusions—CP and Tf levels are representative of clinical status in acute stroke patients. Our findings suggest a protective role of Tf in acute stroke and a possible ambivalent role of CP.


Key words: transferrin • ceruloplasmin • copper • iron • acute stroke